Ulla Westin

Medicine & Life Sciences

1. Secretory Leukocyte Peptidase Inhibitor 100%
2. Immunologic Desensitization 46%
3. Pollen 41%
4. Immunotherapy 35%
5. Poaceae 28%
6. Allergic Rhinitis 24%
7. Leukocytes 21%
8. Allergens 19%
9. Nasal Mucosa 19%
10. Nose 18%
11. Mast Cells 18%
12. Laryngectomy 17%
13. Pancreatic Elastase 17%
14. Immunoglobulin E 17%
15. Serine Proteinase Inhibitors 16%
16. Peptide Hydrolases 16%
17. Interleukin-8 14%
18. Neutrophils 13%
19. Hypersensitivity 13%
20. alpha 1-Antitrypsin Deficiency 12%
21. Leukocyte Elastase 12%
22. Deglutition 12%
23. Protease Inhibitors 12%
24. Elafin 11%
25. Placebos 11%
26. Lung Neoplasms 11%
27. alpha 1-Antitrypsin 11%
28. Histamine Release 10%
29. Upper Esophageal Sphincter 10%
30. Gelsolin 10%
31. AZD8309 9%
32. Oropharyngeal Neoplasms 9%
33. Immediate Hypersensitivity 9%
34. In Situ Hybridization 8%
35. Seasonal Allergic Rhinitis 8%
36. Lipopolysaccharides 8%
37. Aqueous Humor 8%
38. In Vitro Techniques 8%
39. Mucous Membrane 8%
40. Chymases 8%
41. Conditioned Culture Medium 8%
42. Tumor Necrosis Factor Receptors 8%
43. Endotoxins 8%
44. Head and Neck Neoplasms 7%
45. Alveolar Epithelial Cells 7%
46. Squamous Cell Carcinoma of Head and Neck 7%
47. Neoplasms 7%
48. Albumins 7%
49. Bronchoalveolar Lavage Fluid 7%
50. Adiposity 7%